Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis

View source ↗

Summary

A clinical trial is evaluating the effectiveness of combining a disease-modifying therapy with the Yishen Daluo Yin Modified Formula for relapsing-remitting mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disease-modifying therapy
  • Yishen Daluo Yin Modified Formula

Snippet

Sponsor: Ying Gao | Conditions: RRMS | Status: NOT_YET_RECRUITING